Priority Date: 03.06.16 (US 201662345575P)

COMPOSITIONS AND METHODS FOR TUMOR VACCINATION AND IMMUNOTHERAPY INVOLVING HER2/NEU

  • Application ID: EP17807584
  • Status: Request for examination was made

Attorney

Employment test 51 - 200 employees
Company dna j a kemp
no operation time available
1345.74
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61, C07, and C12. J A Kemp is specialized in the combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 127 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 03.06.2016 - Priority Date (US 201662345575P)
  • 07.12.2017 - Publication A1 (WO2017210579)
  • 10.04.2019 - Publication A1 (EP3464560)